This conflicting response to the cartilage breakdown between SOST knock-out mice and the antisclerostin-antibody treatment is probably due to insufficient diffusion of sclerostin in articular cartilage and implies that an additional trigger is required to initiate osteoarthritis [64,66]. This evidence concerns the gene SOST and osteoarthritis.